Pursuit Church Announces ‘United for Israel’ Rally at the University of Washington

Pursuit Church Announces ‘United for Israel’ Rally at the University of Washington

Pursuit NW Stands United for Israel

Pursuit Church Announces ‘United for Israel’ Rally at the University of Washington
Pro-Israel March

Interfaith Rally

The Pursuit NW, under the leadership of Pastor Russell Johnson, is proud to announce its continued commitment to advocating for Israel with the upcoming “United for Israel” rally at the University of Washington on Sunday, May 12th, 2024, at 4:30 p.m. The rally will start at Red Square, with a march through the campus and will conclude at the Pursuit Seattle campus located on UW’s frat row.

Pastor Russell spearheaded the impactful University of Washington march, which convened shortly after the October 7th attacks on Israel. The Seattle event, in collaboration with StandWithUs and Oregon for Israel, featured distinguished guest speaker Mosab Hassan Yousef, renowned for his courageous stance as the “Son of Hamas.”

He went on to direct the recent Pro-Israel rallies at Columbia University and the University of Southern California in collaboration with Sean Feucht, Let Us Worship, Hold the Line, StandWithUs, and various Jewish and Christian groups. The resoundingly successful events drew thousands of attendees representing various faiths. Since the events, the organization has been inundated with requests for similar initiatives to counter the alarming rise of antisemitism on college campuses across America.

Pastor Russell brings a wealth of experience and passion to Pro-Israel initiatives and is excited to return to his home base in Seattle, where the initiative first came to fruition. The Pursuit aims to provide a platform for the majority voice in America amidst media portrayals influenced by minority extremist perspectives. Pastor Johnson emphasizes the rally’s focus on essential issues, including Israel’s right to self-defense, the immediate release of all remaining hostages, and the restoration of lasting peace in the region.


The Pursuit, based in Washington state, is a non-denominational church across multiple campuses, including Seattle, Kirkland, Snohomish, and an online presence. The church’s mission centers on glorifying Jesus and bringing people into an encounter with the presence of God. It’s no coincidence that their Seattle Campus is on the University of Washington’s Frat Row.


Pursuit NW Church | 9051 132nd Ave NE, Kirkland, WA. 98033

Emma LaMarche | emma.l@thepursuitnw.com

Media Intake Coordinator | 425-205-7428 | www.thepursuitnw.com

Contact Information:

Emma LaMarche

Media Intake Coordinator



Original Source:

Pursuit Church Announces ‘United for Israel’ Rally at the University of Washington

The post Pursuit Church Announces ‘United for Israel’ Rally at the University of Washington first appeared on RSVTV news.

Lifescapes Counseling Offers ‘Is It Time for Medication?’ Webinar

Lifescapes Counseling Offers ‘Is It Time for Medication?’ WebinarConnecting People to Professionals

Wondering if it is time to start medication for a mental health issue?  Do you wish you could get an honest answer to your questions about psychotropic medication without committing to treatment or waiting forever for an appointment? What if you could anonymously ask a panel of legitimate professionals your most private questions in real time?

Well, that opportunity is here. A local mental health practice will soon give the public a chance to ask their burning psychiatric medication questions. On May 16th, Lifescapes Counseling will present their second in a series of educational webinars, live via video in an interactive, question-and-answer format. “Is It Time for Medication?” will be presented by experienced licensed mental health providers Kathryn Wriggelsworth, DNP, PMHNP-BC, Ram Miro, DNP, PMHNP-BC, and Amy Moulds, MEd, LCMHCS.

During this webinar, we’ll present basic information about psychotropic medication, including risks/benefits/side effects. We will also explore the reasons many people are anxious to go the psychiatry route and how to decide if it is time to try meds. Participants will also learn why such referrals are made, and how to find a medication provider with whom they feel comfortable. 

The ACCESSlifescapes Webinar Series uses a large group environment to reach people with questions. “We want to provide the opportunity to chat with real therapists in real time at low cost,” says Practice Director Amy Moulds. “It can be hard to identify trustworthy information online, and many people would be surprised to know how common their most guarded questions actually are.”

As therapy requires financial and scheduling commitments that are not feasible for everyone, ACCESSlifescapes offers the opportunity to interact directly with licensed professionals about a range of timely psychological, psychiatric, and behavioral issues, such as school refusal, psychiatric medication, parenting LGBTQIA+ adolescents, eating disorders, etc.  This webinar format will allow participants (who will not be visible) to receive peer support and validation in a private setting. 

Participants will have the opportunity to submit questions privately when completing the online registration. This allows the presenting clinicians to organize the webinar in a manner that will prioritize the most requested information. Participants can ask their questions anonymously during the webinar. Registration is limited and can be accessed here: https://us06web.zoom.us/webinar/register/WN_uWvbppPGRE-QrZf82PCmug.

Past webinar recordings are also available at our website, including “Dealing Effectively with School Refusal.” If you would like to register for the  “Is It Time for Medication?” webinar, or to access the schedule of future webinar topics, please visit www.lifescapescounseling.com/accesslifescapes-webinars.

For questions about the ACCESSlifescapes Webinar Series, please call us at 919.303.0273 or email us at webinars@lifescapescounseling.com. 

Lifescapes Counseling Associates, PLLC is an outpatient mental health practice providing professional psychiatric, psychological, and therapeutic services. Psychological evaluations, medication management, individual, couples, group, and family counseling services are available. Find us at Bradley Commons – 950 Windy Rd, Suite 305, Apex NC 27502 or at www.lifescapescounseling.com, or 919.303.0273.

Contact Information:

Amy Moulds

Practice Director



Original Source:

Lifescapes Counseling Offers ‘Is It Time for Medication?’ Webinar

Freyja HealthCare’s VereSee™ Device Receives 510(k) Clearance, the First of Many Products

Freyja HealthCare’s VereSee™ Device Receives 510(k) Clearance, the First of Many Products

Freyja Healthcare Brings First-of-Its-Kind 2mm Abdominal-Access Device to Laparoscopic Surgery to Further Innovation in Fast-Growing Women’s Health Market

Freyja Healthcare, an early-stage medical device company focused on developing a robust product portfolio of highly innovative products for women’s health, today announced that its novel VereSee device received 510(k) clearance from the United States Food and Drug Administration (FDA). Clearance from the FDA marks a critical step in enabling Freyja and VereSee — the first and only 2mm, safe abdominal-access video-entry device for laparoscopic surgery — to bring further innovation in the fast-growing women’s health market.  VereSee will reinvigorate a category that has not seen innovation in over three decades.

Founded by Jón Ívar Einarsson, MD, PhD, MPH, and Gaby Moawad, MD, FACOG, Freyja’s mission is to raise the standard of women’s health in both surgical and in-office procedures, enabling physicians to deliver safe and effective care. As the company’s first novel product, the VereSee device features a proprietary design engineered to be simple for the surgeon, safe for the patient, and highly differentiated from the current standard of care. The company now has four products in advanced stages of development, 17 granted patents and 21 pending patents.

“From the beginning, I’ve been impressed with Freyja’s mission to improve gynecologic solutions for women and the providers who take care of them. With this first product, Freyja is bringing  meaningful innovation to a category ready for change,” said Kim Rodriguez, longtime Freyja Executive Chairman and former CEO of Acessa Health. 

There are 4.8 million laparoscopic surgeries performed annually in the United States. Abdominal entry is the most dangerous step of laparoscopic and robotic surgery in women’s health, and in all laparoscopic surgery across all specialty areas. This dangerous step results in one patient death and eight injuries in the U.S. each day[1].

“The standard of care is dangerous and outdated. Initial entry is often done blindly with Veres needles or a 5-12mm optical trocar,” said Jón Ívar Einarsson, MD, co-founder and interim CEO of Freyja. “Damaging the bowel or vasculature because of blind entry can cause significant harm, even death, if undetected.” 

As a part of the FDA clearance process, Freyja performed extensive testing and documentation of the safety and efficacy of the product, validating the company’s confidence in the design of its VereSee product. 

“FDA clearance has been a long process for us, and we know that this is one of the largest barriers to entry for new products in this category,” said Gaby Moawad, MD, co-founder and Board Director of Freyja. “However, we understand the importance of these devices being held to the highest standards of safety and quality. We are proud of the work our team has done to reach this milestone for Freyja.”

Freyja will soon begin initial commercialization of the VereSee device, with broad availability expected in the second half of 2024.

About Freyja Healthcare 

Freyja Healthcare was founded in 2017, has four products in advanced stages of development, 17 granted patents and 21 pending patents, and is engineering a robust product portfolio focused on safe and effective surgical and in-office solutions for women. Founded by two well-respected, minimally invasive gynecologic surgeons, Jón Ívar Einarsson, MD, PhD, MPH, Past-President of AAGL, founder of the Division of Minimally Invasive Gynecologic Surgery (MIGS) at Brigham and Women’s Hospital (BWH) and a Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School, and Gaby Moawad, MD, FACOG, Associate Professor of Obstetrics and Gynecology at The George Washington University School of Medicine and Health Sciences (GWSMHS). Drs. Einarsson and Moawad are inventing and building the products they wish they had early in their careers and elevating the standards for products used in women’s health surgical and in-office care. Freyja has raised almost $8 million in seed funding from private and professional high net-worth investors. Learn more at Freyja Healthcare.

[1] Clark NV, Einarsson JI. Laparoscopic entry techniques. In: Minimally invasive surgery in gynecologic practice. De Gruyter 2020.

Contact Information:

Jerry Brecher


Original Source:

Freyja HealthCare’s VereSee™ Device Receives 510(k) Clearance, the First of Many Products

The post Freyja HealthCare’s VereSee™ Device Receives 510(k) Clearance, the First of Many Products first appeared on RSVTV news.